A graph-theoretical approach to Kleinian groupsRENI, M.Proceedings of the London Mathematical Society. 1993, Vol 67, pp 200-224, issn 0024-6115, 1Article

Weekly Docetaxel as Salvage Therapy in Patients with Gemcitabine-Refractory Metastatic Pancreatic CancerCEREDA, S; RENI, M.Journal of chemotherapy. 2008, Vol 20, Num 4, pp 509-512, issn 1120-009X, 4 p.Article

Prognostic value of prostate specific antigen before, during and after radiotherapyRENI, M; BOLOGNESI, A.Cancer treatment reviews. 1998, Vol 24, Num 2, pp 91-99, issn 0305-7372Article

Weak Riemannian structures on gauge-group orbitsBERZI, V; RENI, M.International journal of theoretical physics. 1987, Vol 26, Num 2, pp 151-174, issn 0020-7748Article

Diagnostic and therapeutic management of neuroendocrine lung tumors : A clinical study of 44 casesCARRETTA, A; CERESOLI, G. L; ARRIGONI, G et al.Lung cancer. 2000, Vol 29, Num 3, pp 217-225, issn 0169-5002Article

Therapeutic management of primary central nervous system lymphoma : Lessons from prospective trialsFERRERI, A. J. M; RENI, M; VILLA, E et al.Annals of oncology. 2000, Vol 11, Num 8, pp 927-937, issn 0923-7534Article

Second-line treatment for primary central nervous system lymphomaRENI, M; FERRERI, A. J. M; VILLA, E et al.British journal of cancer. 1999, Vol 79, Num 3-4, pp 530-534, issn 0007-0920Article

Primary central nervous system lymphoma in immunocompetent patientsFERRERI, A. J. M; RENI, M; VILLA, E et al.Cancer treatment reviews. 1995, Vol 21, Num 5, pp 415-446, issn 0305-7372Article

A multi-centre retrospective review of second-line therapy in advanced pancreatic adenocarcinomaRENI, M; BERARDI, R; MAMBRINI, A et al.Cancer chemotherapy and pharmacology. 2008, Vol 62, Num 4, pp 673-678, issn 0344-5704, 6 p.Article

Venous thromboembolism predicts poor prognosis in irresectable pancreatic cancer patientsMANDALA, M; RENI, M; CASCINU, S et al.Annals of oncology. 2007, Vol 18, Num 10, pp 1660-1665, issn 0923-7534, 6 p.Article

Importance of complete staging in non-Hodgkin's lymphoma presenting as a cerebral mass lesionFERRERI, A. J. M; RENI, M; ZOLDAN, M. C et al.Cancer. 1996, Vol 77, Num 5, pp 827-833, issn 0008-543XArticle

Weekly Epirubicin as Salvage Therapy in Patients with Gemcitabine-Resistant Advanced Pancreatic CancerCEREDA, S; ROGNONE, A; MAZZA, E et al.Journal of chemotherapy (Testo stampato). 2009, Vol 21, Num 6, pp 698-700, issn 1120-009X, 3 p.Article

A retrospective analysis of postradiation chemotherapy in 133 patients with glioblastoma multiformeRENI, M; COZZARINI, C; FERRERI, A. J. M et al.Cancer investigation. 2000, Vol 18, Num 6, pp 510-515, issn 0735-7907Article

Consolidation radiotherapy to bulky or semibulky lesions in the management of stage III-IV diffuse large B cell lymphomasFERRERI, A. J. M; DELL'ORO, S; RENI, M et al.Oncology. 2000, Vol 58, Num 3, pp 219-226, issn 0030-2414Article

Meningeal carcinomatosis from transitional cell carcinoma of the bladder : Report of two cases and review of the literatureCOZZARINI, C; RENI, M; MANGILI, F et al.Cancer investigation. 1999, Vol 17, Num 6, pp 402-407, issn 0735-7907Article

Therapeutic management of primary central nervous system lymphoma in immunocompetent patients : Results of a critical review of the literatureRENI, M; FERRERI, A. J. M; GARANCINI, M. P et al.Annals of oncology. 1997, Vol 8, Num 3, pp 227-234, issn 0923-7534Article

Tumour―stroma interactions in pancreatic ductal adenocarcinoma: Rationale and current evidence for new therapeutic strategiesHEINEMANN, V; RENI, M; YCHOU, M et al.Cancer treatment reviews. 2014, Vol 40, Num 1, pp 118-128, issn 0305-7372, 11 p.Article

A preclinical evaluation of pemetrexed and irinotecan combination as second-line chemotherapy in pancreatic cancerMERCALLI, A; SORDI, V; FORMICOLA, R et al.British journal of cancer. 2007, Vol 96, Num 9, pp 1358-1367, issn 0007-0920, 10 p.Article

Temozolomide as salvage treatment in primary brain lymphomasRENI, M; ZAJA, F; MANNO, P et al.British journal of cancer. 2007, Vol 96, Num 6, pp 864-867, issn 0007-0920, 4 p.Article

MATILDE regimen followed by radiotherapy is an active strategy against primary CNS lymphomasFERRERI, A. J. M; DELL'ORO, S; ZAJA, F et al.Neurology. 2006, Vol 66, Num 9, pp 1435-1438, issn 0028-3878, 4 p.Article

Relevance of intraocular involvement in the management of primary central nervous system lymphomasFERRERI, A. J. M; BLAY, J.-Y; TINGUELY, M et al.Annals of oncology. 2002, Vol 13, Num 4, pp 531-538, issn 0923-7534Article

Therapeutic management with adriamycin-containing chemotherapy and radiotherapy of monostotic and polyostotic primary non-hodgkin's lymphoma of bone in adultsFERRERI, A. J. M; RENI, M; CERESOLI, G. L et al.Cancer investigation. 1998, Vol 16, Num 8, pp 554-561, issn 0735-7907Article

Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma: A pharmacokinetic-pharmacodynamic analysis from the IELSG no. 20 trialJOERGER, M; HUITEMA, Adr; KRÄHENBÜHL, S et al.British journal of cancer. 2010, Vol 102, Num 4, pp 673-677, issn 0007-0920, 5 p.Article

Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinomaRENI, M; CEREDA, S; BONETTO, E et al.Cancer chemotherapy and pharmacology. 2007, Vol 59, Num 3, pp 361-367, issn 0344-5704, 7 p.Article

Neoadjuvant phase II multicentre study of new agents in patients with malignant glioma after minimal surgery. Report of a cohort of 187 patients treated with temozolomideBRADA, M; ASHLEY, S; WILKINS, P et al.Annals of oncology. 2005, Vol 16, Num 6, pp 942-949, issn 0923-7534, 8 p.Article